Adamas to Present at Upcoming Healthcare Conferences
February 17 2021 - 4:06PM
Business Wire
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated
to developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that Neil F. McFarlane, Chief Executive Officer, is
scheduled to present at the following investor conferences:
- 10th Annual SVB Leerink Global Healthcare Conference on
Wednesday, February 24 at 1:40 p.m. ET (10:40 a.m. PT)
- Cowen 41st Annual Healthcare Conference on Tuesday, March 2 at
2:50 p.m. ET (11:50 a.m. PT)
- H.C. Wainwright Global Life Sciences Conference. Prerecorded
presentation available starting on Tuesday, March 9 at 7:30 a.m. ET
(4:30 a.m. PT)
The webcasts will be accessible on the investor relations
section of the Adamas website at
http://ir.adamaspharma.com/events-presentations and will be
available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines
that reduce the burden of neurological diseases on patients,
caregivers and society. We are a fully integrated company focused
on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
Source: Adamas Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210217005975/en/
Media: Sarah Mathieson Vice President, Corporate
Communications 510-450-3528 smathieson@adamaspharma.com
Investors: Peter Vozzo Managing Director Westwicke/ICR
443-213-0505 peter.vozzo@westwicke.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From May 2024 to Jun 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From Jun 2023 to Jun 2024